Cell therapies are in the process of revolutionizing the medical field. Last February, a pioneer of cell therapy, Carl June, reported that the second patient to ever receive a chimeric antigen ...
CHICAGO--(BUSINESS WIRE)--CORE Industrial Partners (“CORE”), a manufacturing, industrial technology, and industrial services-focused private equity firm, announced today the acquisition of Elite ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results